Evernorth includes the specialty pharmacy Accredo, which treats about 1 million patients annually, and specialty distributor CuraScript, which serves more than 12,000 providers. In addition ...

5, 2024 /PRNewswire/ -- Evernorth Health Services announced that it plans to have a Stelara biosimilar available for $0 out of pocket for eligible patients of its specialty pharmacy, Accredo ...

BLOOMFIELD, Conn., Sept. 5, 2024 /PRNewswire/ -- Evernorth Health Services announced that it plans to have a Stelara biosimilar available for $0 out of pocket for eligible patients of its specialty ...

Estimated to save individual Accredo patients around $4,000 per year Biosimilar price will be more than 80% lower than Stelara list price Accredo patients benefit from the specialty pharmacy's best-in ...

TRICARE is coming under fire for its decision to renew a multibillion-dollar contract to Express Scripts to manage the U.S. military’s health care program’s pharmacy benefits. Independent ...

Ensuring prescriptions for limited-distribution drugs are filled in-network via an in-house specialty pharmacy enables close integration between the pharmacy and care teams which ultimately leads ...

Accredo has served as Tricare’s primary in-network specialty pharmacy since the beginning of 2023, though patients can buy specialty drugs through other pharmacies as well. Both companies are ...

Walgreens announced this week that it is expanding its specialty pharmacy offerings to include cell and gene therapy services. The move could allow Walgreens to play a bigger role in a growing ...

"Not all biosimilars are created equal," Matt Perlberg, president of Cigna's Evernorth Health Services' pharmacy and care ... per year for some of the 100,000 Accredo patients currently using ...